G. Verleden (Leuven, Belgium), C. Pison (Grenoble, France)
Health-related quality of life as predictor of survival in lung transplant candidates
K. Stavem, O. Bjørtuft, K. Kongshaug, O. R. Geiran, J. Boe (Nordbyhagen, Oslo, Norway)
|  |
Effect of 3 preservation solutions on early outcome on 79 consecutive lung transplantations
C. Saint Raymond, C. Sessa, D. Hacini, P. Y. Brichon, P. Chaffanjon, A. Bonadona, O. Chavanon, M. Durand, C. Pison, D. Blin (Grenoble, France)
| |
Patterns of RSV-infection in adult lung transplant patients during epidemic occurrence of RSV-infections
C. Geltner, A. Gschwendtner, C. Larcher, L. Mueller (Natters, Austria)
| |
Monocyte chemoattractant protein-1 levels in broncho-alveolar lavage fluid of lung transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection
F. Meloni, A. Cascina, E. Paschetto, A. Marone Bianco, M. Morosini, A. Fietta, P. Vitulo, E. Pozzi, M. Viganò (Pavia, Italy)
| |
Air travel in patients with advanced lung disease
J. C. Rendall, K. Clapperton, J. McCarthy, A. E. Woods, J. Dark, P. A. Corris, J. J. Egan (Dublin, Ireland; Newcastle, United Kingdom)
| |
Health-related quality of life in lung recipients with chronic rejection
M. W. Gerbase, A. Spiliopoulos, T. Rochat, L. P. Nicod (Geneva, Switzerland)
| |
Health-related quality of life before and after lung transplantation
K. Stavem, O. Bjørtuft, K. Kongshaug, O. R. Geiran, J. Boe (Nordbyhagen, Oslo, Norway)
| |
Gene expression of growth factors in the airway mucosa from human lung allografts
J. D. Aubert, B. Carnal, J. Wellinger (Lausanne, Switzerland)
| |
Exhaled carbon monoxide in patients with bronchiolitis obliterans after lung transplantation
J. R. Ruis, D. J. Slebos, W. van der Bij, D. S. Postma, H. F. Kauffman, G. H. Koëter (Groningen, The Netherlands)
| |
IL-8 in BAL-fluid of lung transplant patients: a possible predictive factor for upcoming acute rejection?
B. Vanaudenaerde, W. Wuyts, L. Dupont, D. Van Raemdonck, M. Demedts, G. Verleden (Leuven, Belgium)
| |
Changes in exhaled nitric oxide (eNO) over time in stable lung transplant recipients without chronic rejection
A. Van Muylem, M. Estenne (Brussels, Belgium)
| |
Balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the development of bronchiolitis obliterans syndrome after lung transplantation
R. H. Hubner, U. Mundt, S. W. Hirt, U. R. Folsch, B. Bewig (Kiel, Germany)
| |
Expression of Interleukin-8, Interferon-γ and TNF- α in surveillance bronchoscopies after lung transplantation
C. Eich, R. Speich, S. Irani, E. W. Russi, W. Weder, A. Boehler (Zurich, Switzerland)
| |
Influence of recipient age on airway obliteration after tracheal allotransplantation in mice
K. Remund, Z. Guo, T. Rechsteiner, P. Vogt, P. Sandera, E. W. Russi, A. Boehler (Zurich, Switzerland)
| |
Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation
H. Wilkens, A. Grgic, M. Uder, O. Wendler, H. J. Schäfers, G. W. Sybrecht (Hamburg, Germany)
| |
The blockade of substance P receptors avoids the derangement of the vascular permeability during experimental donor-lung preservation
J. L. Arreola, L. M. Montaño, E. Flores, B. Sommer, M. H. Vargas (Mexico City, Mexico)
| |
Effects of cold preservation on the whole lung and lung tissue mechanics in the rat
K. Ikeyama, H. Sakai, M. Omasa, T. Nakamura, T. Bando, S. Hasegawa, H. Wada (Kyoto, Japan)
| |
Infections increase exhaled nitric oxide, but not carbon monoxide levels in lung transplant recipients
B. Antus, E. Csiszer, K. Czebe, I. Horvath (Budapest, Hungary; Vienna, Austria)
| |
Comparison of chest physiotherapy versus postive expiratory pressure therapy on outcome after unilateral lung transplantion
J. L. Tarnow, B. M. Daniel (San Francisco, United States Of America)
| |